| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744846 | Clinical Microbiology and Infection | 2018 | 22 Pages |
Abstract
Under well-designed treatment and management scheme, high treatment success rates were achieved in a high-MDR-TB-burden country. Antimicrobial susceptibility testing for all second-line drugs should be conducted to further assist in the treatment of MDR-TB.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X. Wang, Z. Jia,